C63.8 — Malignant neoplasm of overlapping sites of male genital organs
Billable
Is C63.8 billable?
Yes — C63.8 is billable for FY2027. C63.8 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C63.8 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C63.8 at a glance
| Code | C63.8 |
|---|---|
| Description | Malignant neoplasm of overlapping sites of male genital organs |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C63.8 group to?
C63.8 sits in MDC 12 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 715Male Reproductive System and Other O.R. Procedures for Malignancy with CC/MCCsurgical
- 716Male Reproductive System and Other O.R. Procedures for Malignancy without CC/MCCsurgical
Inclusion terms
Alternative wording in documentation that is classified to C63.8.
- Primary malignant neoplasm of two or more contiguous sites of male genital organs whose point of origin cannot be determined
How long has C63.8 existed?
C63.8 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.